NCT04818749View on ClinicalTrials.gov

Combined Intravenous Dexamethasone and Dexmedetomidine as Adjuncts to Popliteal and Saphenous Nerve Blocks in Patients Undergoing Orthopaedic Surgery of the Foot and Ankle

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

June 2, 2021

Primary Completion Date

April 17, 2023

Study Completion Date

May 17, 2023

Conditions
Anesthesia, Local
Interventions
DRUG

Saline

Saline (placebo) will be administered intravenously before block performance and after the induction of general anaesthesia.

DRUG

Dexamethasone 12 mg

Dexamethasone 12 mg will be administered intravenously before block performance and saline (placebo) will be administered intravenously after the induction of general anaesthesia.

DRUG

Dexamethasone 12 mg + dexmedetomidine 1 mcg/kg

Dexamethasone 12 mg will be administered intravenously before block performance and dexmedetomidine 1 mcg/kg will be administered intravenously after the induction of general anaesthesia.

Trial Locations (2)

2400

Department of Anaesthesiology, Bispebjerg Hospital, Copenhagen

4600

Department of Anaesthesiology, Køge

All Listed Sponsors
lead

Zealand University Hospital

OTHER